NYSE : AGL
agilon health, inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 85.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.44B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.43B |
| Enterprise Value | 1.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 16.79M |
| Shares Outstanding | 16.79M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | +3.31% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 64.82% |
| Float | 10.93M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 52.14 |
| PS Ratio | 0.24 |
| Forward PS | 0.24 |
| PB Ratio | 6.26 |
| P/TBV Ratio | 8.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.08 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.44 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -78.94% |
| Return on Assets (ROA) | -9.61% |
| Return on Invested Capital (ROIC) | -44.65% |
| Return on Capital Employed (ROCE) | -91.07% |
| Weighted Average Cost of Capital (WACC) | 21.23% |
| Revenue Per Employee | $6.92M |
| Profits Per Employee | -$271,282 |
| Employee Count | 856 |
| Asset Turnover | 3.58 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 646,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 3.11 |
| 52-Week Price Change | +293.24% |
| 50-Day Moving Average | 87.87 |
| 200-Day Moving Average | 64.99 |
| Relative Strength Index (RSI) | 44.01 |
| Average Volume (20 Days) | 183,802 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 899,148 |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 5.35% |
| Short % of Float | 8.23% |
| Short Ratio (days to cover) | 3.93 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.92B |
| Gross Profit | 13.84M |
| Operating Income | -254.07M |
| Pretax Income | -250.57M |
| Net Income | -232.22M |
| EBITDA | -239.72M |
| EBIT | -254.07M |
| Loss Per Share | -$13.97 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 185.63M |
| Total Debt | 33.45M |
| Net Cash | 152.18M |
| Net Cash Per Share | $9.06 |
| Equity (Book Value) | 227.53M |
| Book Value Per Share | 13.56 |
| Working Capital | 106.19M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -72.26M |
| Capital Expenditures | -12.69M |
| Depreciation & Amortization | 14.35M |
| Net Borrowing | -3.50M |
| Free Cash Flow | -84.95M |
| FCF Per Share | -$5.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 0.23% |
| Operating Margin | -4.29% |
| Pretax Margin | -4.23% |
| Profit Margin | -3.92% |
| EBITDA Margin | -4.05% |
| EBIT Margin | -4.29% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.57% |
| Shareholder Yield | n/a |
| Earnings Yield | -16.46% |
| FCF Yield | -5.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $115.83 |
| Price Target Difference | 36.43% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 5.43% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.85 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |